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multidimensional NMR spectroscopy. In total, 97% of all 
backbone resonances were assigned in the complex, with 
385 out of a possible 399 residues assigned in the 1H–15N 
TROSY spectrum. Prediction of solution secondary struc-
ture from a chemical shift analysis using the TALOS-N web-
server is in good agreement with the published X-ray crystal 
structure of this complex.
Keywords Backbone resonance assignment · Transverse 
relaxation optimised spectroscopy · Phosphoryl transfer 
enzyme · Transition state analogue · Magnesium trifluoride
Biological context
Phosphoglycerate kinase (PGK, EC 2.7.2.3) is a bisub-
strate magnesium-dependent enzyme with highly 
conserved amino acid sequences found in all living 
organisms. In glycolysis, it catalyses the transfer of a 
phosphoryl group from 1,3-bisphosphoglycerate (BPG) 
to ADP producing 3-phosphoglycerate (3PG) and ATP, 
while in gluconeogenesis and in the Calvin cycle of pho-
tosynthetic species, PGK catalyses the reverse reaction. 
In mammals, PGK has further roles in oncogenesis and 
cellular metabolism, which have been exploited to provide 
targets for cancer treatments and retroviral infections. 
Elevated PGK concentrations in fibrosarcoma tumours 
promotes disulphide-bond reduction of plasmin resulting 
in a decrease in tumour vascularity, tumour growth and 
metastatic ability due to an increase in the plasma levels 
of angiostatin (an inhibitor of blood vessel development) 
(Lay et al. 2000). PGK activity in cell nuclei also modu-
lates DNA replication, transcription and repair (Popanda 
et al. 1998) and this role has been utilised to generate 
and maintain equilibrium levels of l-nucleoside analogues 
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(clinically active anticancer and antiviral treatments) 
through in vivo phosphorylation by PGK (Krishnan et al. 
2003; Mathé and Gosselin 2006). There are two isoforms 
of human PGK which share 88% amino acid sequence 
identity: PGK1 is expressed in all cells, whereas PGK2 
expression is confined to spermatogenic cells undergoing 
meiosis.
PGK is composed of two α/β Rossmann-fold domains 
linked by a central α-helix (F187−E201), with each 
domain comprising seven α-helices arranged around a 
six-stranded parallel β-sheet core together with a three-
stranded antiparallel β-sheet insertion in the C-domain. 
The active site is located in the cleft formed between the 
N-domain which binds BPG or 3PG, and the C-domain 
which binds the nucleotides ADP or ATP. Several X-ray 
structures have been solved for PGK showing the domains 
in an open conformation [e.g. a PGK:ATP complex (Flach-
ner et al. 2004)] and partly closed conformations [e.g. a 
PGK:3PG:ADP complex (Bernstein et al. 1997) and a 
PGK:3PG:AMP-PNP complex (Auerbach et al. 1997)], 
and a structural analysis (Zerrad et al. 2011) has proposed 
that the conformation of the enzyme in solution has a ther-
modynamic preference for the open form resulting from 
the protection from solvent of a hydrophobic patch located 
on the central α-helix.
Aluminium tetrafluoride  (AlF4−), magnesium trif-
luoride  (MgF3−) and transition metal oxoanion moie-
ties have been used widely as transition state analogues 
(TSAs) of the trigonal planar  PO3− group in phosphoryl-
transfer reactions (Wittinghofer 1997; Baxter et al. 2008, 
2010; Jin et  al. 2014, 2017; Wlodawer et  al. 1983). 
Using metal-fluoride approaches, a fully closed human 
PGK:3PG:MgF3:ADP TSA complex was solved to a 
resolution of 1.47 Å (PDB: 2WZB; Cliff et  al. 2010), 
in which clear electron density in the active site places 
the donor and acceptor oxygen atoms of 3PG and ADP 
(donor–acceptor distance = 4.3 Å) as apical ligands for a 
central trigonal bipyramidal  MgF3− group occupying the 
position of the transferring  PO3− group during the phos-
phoryl transfer reaction. The three equatorial fluoride 
atoms are hydrogen bonded by backbone amide groups, 
polar sidechains and the octahedrally coordinated catalytic 
 MgII ion  (F1 − K215:εNH3+ and  MgII;  F2 − R38:ζNH2 and 
G373:HN;  F3 − K219:εNH3+, G396:HN and  H2O). Three 
discrete 19F resonances are clearly visible in a 19F NMR 
spectrum of this complex in solution  (F1 = −160 ppm,  F2/
F3 = −153 and −156 ppm; Cliff et al. 2010) indicating that 
there is no significant intersite exchange on the millisec-
ond timescale. In this work we report the 1H, 15N and 13C 
backbone resonance assignments of human PGK in the 
fully closed PGK:3PG:MgF3:ADP TSA complex, which 
represents the solution conformation of the X-ray crystal 
structure reported previously (PDB: 2WZB).
Methods and experiments
Protein expression and purification
A synthetic human PGK1 gene inserted into a pET-3a plas-
mid vector was purchased from GenScript. The plasmid was 
transformed into Escherichia coli strain BL21(DE3) cells 
(Stratagene) and 2H,15N,13C-labelled human PGK (43 kDa) 
was expressed in defined isotopically labelled minimal 
media, following the protocol of Reed et al. (2003). The 
cells were grown at 37 °C with shaking until  OD600nm = 0.8 
and were induced by the addition of 1 mM isopropyl-β-d-
thiogalactopyranoside (IPTG). After further incubation for 
12 h, cells were harvested by centrifugation at 4000 rpm for 
25 min at 4 °C. The cell pellet was resuspended in buffer 
A (10 mM sodium phosphate buffer pH 6.2, 1 mM DTT, 
1 mM EDTA) supplemented with cOmplete™ protease 
inhibitor cocktail (Roche) (one tablet per 50 mL of buffer). 
The cell suspension was lysed on ice by sonication for 12 
cycles of pulsation for 15 s with 45 s cooling intervals. 
The cell lysate was then separated by ultracentrifugation at 
39,800×g (17,000 rpm) for 25 min at 4 °C in a Beckman 
Coulter Avanti J–E centrifuge using rotor JA 17. Ammonium 
sulphate was added slowly with gentle agitation to the super-
natant to 40% saturation (246 g L−1). Following complete 
solubilisation of the ammonium sulphate, the solution was 
centrifuged as before to pellet unwanted insoluble proteins. 
The supernatant was removed carefully and ammonium sul-
phate was added slowly with gentle agitation to 80% satura-
tion (284 g  L−1) to precipitate PGK, which was pelleted as 
before by centrifugation. The pellet was resuspended care-
fully in buffer A and the protein solution was treated with 
10 mg  mL–1 protamine sulphate (Sigma-Aldrich) for 1 h to 
precipitate nucleotides, which were removed by centrifuga-
tion. The supernatant was filtered using a 0.22 μm syringe 
filter (Sartorius Mechatronics UK Ltd.) and was dialysed 
against 4 L of buffer A for 6 h at 4 °C, followed by a further 
4 L of buffer A for an additional 6 h. The protein sample 
was filtered through a 0.22 µm syringe filter and loaded onto 
a CM-Sepharose cation exchange column (Sigma-Aldrich) 
connected to an ÄKTA purification system (GE Healthcare) 
that had been washed previously with 5 column volumes of 
filtered and degassed buffer A, followed by 5 column vol-
umes of filtered and degassed buffer B (buffer A containing 
1 M NaCl) and equilibrated with at least 5 column volumes 
of filtered and degassed buffer A. Proteins bound to the CM-
Sepharose column were eluted with a gradient of 0 to 100% 
buffer B. PGK elutes as a well-defined peak at around 20% 
buffer B. Fractions containing PGK were checked for purity 
by SDS–PAGE, were pooled together and were concentrated 
by Vivaspin (10 kDa MWCO, GE Healthcare). Once puri-
fied, back exchange to amide protium atoms in perdeuterated 
PGK was promoted by an unfolding-refolding process. The 
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Fig. 1  1H–15N TROSY spectrum of the PGK:3PG:MgF3:ADP TSA complex recorded at pH 7.4 and 298  K. The assignments of backbone 
amide resonances are indicated by sequence number and residue type as defined in the crystal structure (PDB: 2WZB)
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PGK sample was exchanged into buffer C (50 mM Tris–HCl 
buffer pH 7.4, 5 mM  MgCl2, 20 mM DTT, 1 mM EDTA) 
by repeated dilution-concentration steps (three times) by 
Vivaspin. Protein unfolding was initiated by mixing the 
sample with buffer C containing 6 M GuHCl, in a ratio such 
that the final concentration of GuHCl was 2.9 M. Protein 
refolding was achieved by rapid 30-fold dilution of the 
PGK sample into buffer C. Finally, the PGK solution was 
concentrated to NMR sample concentrations by Vivaspin 
and dialysed three times against 1 L of buffer C for 4 h at 
4 °C, to remove GuHCl from the unfolding step. Protein 
concentrations were estimated by absorbance at 280 nm 
(ε280 = 27,960 M− 1  cm− 1). All reagents including the stable 
isotopically-labelled compounds 15NH4Cl (99%), 13C6,2H7-
d-Glucose (U–13C6, 99%; 1,2,3,4,5,6,6-d7 97–98%) and 
2H2O (99.8%) were purchased with the highest purity from 
Sigma-Aldrich and used as received.
NMR spectroscopy
All NMR experiments were recorded at 298  K, using 
standard pulse sequences on an 800 MHz Bruker Avance 
III NMR spectrometer equipped with a TCI cryoprobe, Z 
gradients and TopSpin software version 3.2, housed in the 
Manchester Institute of Biotechnology. NMR samples con-
taining 0.5 mM 2H,15N,13C-labelled human PGK, 10 mM 
3PG, 10 mM ADP, 10 mM  MgCl2, 30 mM  NH4F in 50 mM 
Tris–HCl buffer pH 7.4, 20 mM DTT, 1 mM EDTA and 
0.04% v/v  NaN3 were loaded into 5-mm diameter NMR 
tubes. 2H2O (10% v/v) and trimethylsilyl propanoic acid 
(TSP; 0.5% v/v) were added to the NMR samples for the 
deuterium lock and as a chemical shift reference, respec-
tively. 1H chemical shifts were referenced to the internal TSP 
signal, whereas 15N and 13C chemical shifts were referenced 
indirectly using nuclei-specific gyromagnetic ratios. For the 
backbone 1H, 15N and 13C resonance assignment, standard 
Bruker 1H–15N TROSY and TROSY-based 3D versions of 
HNCA, HNCACB, HN(CO)CACB, HN(CA)CO and HNCO 
experiments were acquired using non-uniform sampling with 
a multidimensional Poisson Gap scheduling strategy with 
sinebell weighting (Hyberts et al. 2013). A 30 Hz (0.15 ppm) 
resolution in the 13C dimension was obtained after process-
ing. The HNCO spectrum, with one peak per residue in 
the 13C dimension was obtained with 230 hypercomplex 
points, whereas spectra with two peaks per residue [HNCA, 
HN(CO)CACB, HN(CA)CO] were obtained with 460 hyper-
complex points and the HNCACB spectrum with four peaks 
per residue was obtained with 920 hypercomplex points.
Resonance assignments and data deposition
Backbone 1HN, 15N, 13Cα, 13Cβ and 13C′ resonances were 
assigned for human PGK in the PGK:3PG:MgF3:ADP 
TSA complex using standard triple resonance methodol-
ogy (Gardner and Kay 1998). Spectra were processed with 
TopSpin software version 3.2. Peak picking and frequency 
matching was performed within CcpNmr Analysis version 
2.4 (Vranken et al. 2005) and the backbone assignments 
were confirmed independently using a simulated annealing 
algorithm employed by the “asstools” assignment program 
(Reed et al. 2003). The backbone 1H, 15N and 13C chemical 
shifts have been deposited in the BioMagResBank (http://
www.bmrb.wisc.edu/) under the BMRB accession code 
27022. The human PGK1 construct used in this study results 
in the PGK protein sequence M1-S2-L3-S4-N5……I417, 
whereas the residue numbering used in the X-ray crystal 
structure of the PGK:3PG:MgF3:ADP TSA complex is 
defined as S1-L2-S3-N4……I416. For clarity and ease of 
comparison, the crystal structure nomenclature has been 
used here throughout.
Excluding the 17 proline residues and the N-terminal 
methionine from the 417-residue PGK protein sequence, 385 
out of a total of 399 residues were assigned in the 1H–15N 
TROSY spectrum of the PGK:3PG:MgF3:ADP TSA com-
plex (Fig. 1). In total, 97% of all backbone resonances were 
assigned (96% of 1HN, 96% of 15N, 98% of 13Cα, 98% of 13Cβ 
and 98% of 13C′ nuclei). There are 14 residues that remain 
unassigned in the 1H–15N TROSY spectrum (S1, L2, S3, N4, 
N30, N31, C49, A144, V216, T242, V283, G373, T375 and 
G396) and their 1H-15N TROSY correlations are likely to be 
attenuated beyond detection by either fast exchange with sol-
vent or intermediate exchange broadening on the millisecond 
Fig. 2  Cartoon representation of the crystal structure of the 
PGK:3PG:MgF3:ADP TSA complex showing the extent of backbone 
amide resonance assignments. Assigned residues are coloured white 
and tan, proline residues are coloured green and unassigned residues 
are coloured purple. The ligands 3PG,  MgF3− and ADP are indicated 
as CPK-coloured sticks and the catalytic magnesium ion is shown as 
a green sphere. For clarity, the β-strands have been coloured tan to 
highlight the domain structure of PGK
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timescale (Fig. 2). For the backbone amide groups of both 
G373 and G396, an additional source of signal attenuation 
arises from 1-bond 1H−19F coupling and 2-bond 15N−19F 
coupling through hydrogen bonding to  F2 and  F3 respectively 
of the  MgF3− moiety (Baxter et al. 2010).
The secondary structure content of PGK was predicted 
by uploading the backbone 1HN, 15N, 13Cα, 13Cβ and 13C′ 
chemical shifts of the PGK:3PG:MgF3:ADP TSA complex 
to the TALOS-N webserver (Shen and Bax 2013). Figure 3 
illustrates the comparison between the predicted second-
ary structure for the solution PGK:3PG:MgF3:ADP TSA 
complex and the secondary structure present in the crys-
tal. These data are in very good agreement, which indicates 
that the solution conformation is similar to the protein struc-
ture observed in the crystal, and provides confidence in the 
assignments of the PGK:3PG:MgF3:ADP TSA complex.
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